Ülke: İrlanda
Dil: İngilizce
Kaynak: HPRA (Health Products Regulatory Authority)
Carprofen
Chanelle Pharmaceuticals Manufacturing Limited
QM01AE91
Carprofen
20 mg/tablet
Tablet
POM: Prescription Only Medicine as defined in relevant national legislation
Dogs
carprofen
N.S.A.I.D.
Authorised
2006-06-02
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Austiofen 20 mg Tablets for dogs. 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE INGREDIENT Carprofen 20.0 mg/tablet EXCIPIENTS For a full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Tablet. A plain round flat bevelled edge white tablet with a breakline on one side. The tablets can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES Reduction of inflammation and pain caused by musculo-skeletal disorders and degenerative joint disease. As a follow up to parenteral analgesia in the management of post-operative pain. 4.3 CONTRAINDICATIONS Do not use in cats. Do not use in pups less than 4 months of age Do not use in case of hypersensitivity to active substance or to any of the excipients. Do not use in dogs suffering from cardiac, hepatic or renal disease, where there is a possibility of gastro-intestinal ulceration or bleeding, or where there is evidence of a blood dyscrasia. Refer to section 4.7. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Refer to sections 4.3 and 4.5 I R I S H M E D I C I N E S B O A R D ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ ___ _D_ _a_ _t_ _e_ _ _ _P_ _r_ _i_ _n_ _t_ _e_ _d_ _ _ _2_ _6_ _/_ _0_ _7_ _/_ _2_ _0_ _1_ _1_ _C_ _R_ _N_ _ _ _7_ _0_ _1_ _0_ _8_ _2_ _4_ _p_ _a_ _g_ _e_ _ _ _n_ _u_ _m_ _b_ _e_ _r_ _:_ _ _ _1_ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Use in aged dogs may involve additional risk. If such a use cannot be avoided, dogs may require careful clinical ma Belgenin tamamını okuyun